BeStock  
Stocks › Biotechnology › TLX

Telix Pharmaceuticals TLX

US equityMarket cap rank #2480Biotechnology
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings95.2x
CheapRich

Below its usual level · 40th percentile, 5-year average 40.9x

#2803 of 2993 stocks by PE (1 = cheapest)

Price / book7.5x
CheapRich

Below its usual level · 36th percentile, 5-year average 9.4x

#4771 of 5330 stocks by PB (1 = cheapest)

Price / sales3.5x
CheapRich

Below its usual level · 23rd percentile, 5-year average 5.9x

#3454 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-666x-283x100x483xJun '24Aug '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$11.60
Price vs. fair value-27.9%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.53 – 9.37 36% (cheaper than usual) #4771 of 5330 (1 = cheapest)
PE 95.15 312.55 40.89 40% (cheaper than usual) #2803 of 2993 (1 = cheapest)
PS 3.51 3.09 5.89 23% (cheaper than usual) #3454 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TLX.

Sign in to join the discussion.

Scroll to Top